Specifically, 0.35% GS can alleviate symptoms of hepatic steatosis; significantly reduce the levels of AST, TG, and MDA in serum; and increase the levels of ALB and GSH-Px (<i>p</i> < 0.05). Here, ALB is linked to fatty liver disease.